GLUCK FREDERICK W 4
4 · CytomX Therapeutics, Inc. · Filed Sep 27, 2017
Insider Transaction Report
Form 4
GLUCK FREDERICK W
Director
Transactions
- Sale
Common Stock
2017-09-26$17.30/sh−5,000$86,476→ 321,643 total(indirect: By Trust)
Holdings
- 22,111(indirect: By LLC)
Common Stock
- 3,200(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.10 to $17.76, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997.
- [F4]Richlin Partners, LLC is an entity owned of record by the spouse of the Reporting Person.